HLC also joined a coalition letter urging CMS not to finalize proposed changes to remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) in the 2027 Physician Fee Schedule proposed rule that would restrict clinically integrated partnerships and create new operational barriers to delivering these services. The letter warned that the proposals could disrupt access to technology-enabled care for Medicare beneficiaries, particularly those managing chronic conditions, and undermine efforts to advance more proactive, coordinated care models.
To The Administration
Group letter to CMS opposing proposed remote monitoring restrictions in the 2027 Physician Fee Schedule
- Topics: Access, Health Information Technology, Value-Based Care
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To The Administration
Group letter to CMS opposing proposed remote monitoring restrictions in the 2027 Physician Fee Schedule
HLC also joined a coalition letter urging CMS not to finalize proposed changes to remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) in the 2027 Physician Fee Schedule proposed rule that would restrict clinically integrated …
To Congress
Group letter to the Committee on Education and Workforce urging House passage of S. 2120, the Older Americans Act (OAA) Reauthorization Act
HLC joined the Healthy Aging Coalition in urging the House to pass S. 2120, the Older Americans Act Reauthorization Act, following its bipartisan passage in the Senate. The letter emphasizes the importance of aging-network services, including nutrit…
To Congress
HLC response to Senate Finance Committee Democrats’ RFI on Drug Pricing
HLC urged Congress to preserve incentives for continued biopharmaceutical innovation while pursuing solutions that improve affordability for beneficiaries. The letter raised concerns about proposals to expand Medicare drug price negotiation and impo…
